Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Clinical trial NCT02892123 · COMPLETED
Trial details
- NCT number
- NCT02892123
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2024-10-31
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.